STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more
Market Cap & Net Worth: STERIS plc (STE)
STERIS plc (NYSE:STE) has a market capitalization of $21.61 Billion ($21.61 Billion) as of March 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #911 globally and #709 in its home market, demonstrating a -3.33% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying STERIS plc's stock price $220.13 by its total outstanding shares 98147009 (98.15 Million).
STERIS plc Market Cap History: 2015 to 2026
STERIS plc's market capitalization history from 2015 to 2026. Data shows growth from $6.70 Billion to $21.61 Billion (13.15% CAGR).
Index Memberships
STERIS plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$53.17 Trillion | 0.05% | #335 of 503 |
Weight: STERIS plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
STERIS plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how STERIS plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.56x
STERIS plc's market cap is 4.56 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
40.48x
STERIS plc's market cap is 40.48 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.09 Billion | $2.24 Billion | $110.76 Million | 2.72x | 54.97x |
| 2017 | $8.02 Billion | $2.61 Billion | $109.97 Million | 3.07x | 72.94x |
| 2018 | $9.92 Billion | $2.62 Billion | $290.92 Million | 3.79x | 34.09x |
| 2019 | $14.29 Billion | $2.78 Billion | $304.05 Million | 5.14x | 47.00x |
| 2020 | $17.94 Billion | $3.03 Billion | $407.66 Million | 5.92x | 44.00x |
| 2021 | $23.22 Billion | $3.11 Billion | $397.40 Million | 7.47x | 58.43x |
| 2022 | $17.78 Billion | $4.22 Billion | $243.89 Million | 4.21x | 72.90x |
| 2023 | $21.37 Billion | $4.54 Billion | $107.03 Million | 4.71x | 199.69x |
| 2024 | $20.18 Billion | $5.14 Billion | $378.24 Million | 3.93x | 53.34x |
| 2025 | $24.88 Billion | $5.46 Billion | $614.64 Million | 4.56x | 40.48x |
Competitor Companies of STE by Market Capitalization
Companies near STERIS plc in the global market cap rankings as of March 18, 2026.
Key companies related to STERIS plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
STERIS plc Historical Marketcap From 2015 to 2026
Between 2015 and today, STERIS plc's market cap moved from $6.70 Billion to $ 21.61 Billion, with a yearly change of 13.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $21.61 Billion | -13.17% |
| 2025 | $24.88 Billion | +23.33% |
| 2024 | $20.18 Billion | -5.60% |
| 2023 | $21.37 Billion | +20.20% |
| 2022 | $17.78 Billion | -23.43% |
| 2021 | $23.22 Billion | +29.47% |
| 2020 | $17.94 Billion | +25.50% |
| 2019 | $14.29 Billion | +44.09% |
| 2018 | $9.92 Billion | +23.66% |
| 2017 | $8.02 Billion | +31.73% |
| 2016 | $6.09 Billion | -9.14% |
| 2015 | $6.70 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of STERIS plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.61 Billion USD |
| MoneyControl | $21.61 Billion USD |
| MarketWatch | $21.61 Billion USD |
| marketcap.company | $21.61 Billion USD |
| Reuters | $21.61 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.